Get the Stockscreener App
284.02
0.83%
2.34
After Hours:
283.01
-1.01
-0.36%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc Stock (AMGN) Latest News
Ibex Wealth Advisors Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Here's Why Amgen (AMGN) is a Strong Momentum Stock - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Sold by New England Research & Management Inc. - MarketBeat
Milestone Asset Management LLC Buys 2,685 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AMGN: 3 Biotech Stocks Revolutionizing Healthcare - StockNews.com
Citigroup Has Lowered Expectations for Amgen (NASDAQ:AMGN) Stock Price - Defense World
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress - MSN
Federal Court delists Regeneron patent, clearing path for Amgen biosimilar launch - Law360 Canada
Swedbank AB Buys 25,482 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Set to Report Q4 Earnings: Is a Beat in the Cards? - MSN
Forsta AP Fonden Sells 4,200 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Premenstrual Syndrome Treatment Market May See Big Move: Major - openPR
Here's Why Amgen (AMGN) is a Strong Value Stock - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Foster Victor Wealth Advisors LLC - MarketBeat
Montrusco Bolton Investments Inc. Sells 375,906 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
BMO Capital Adjusts Price Target on Amgen to $346 From $362, Keeps Outperform Rating - Marketscreener.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Amgen and Celltrion settle biosimilars patent dispute - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Twelve Points Wealth Management LLC - MarketBeat
Perigon Wealth Management LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Blue Trust Inc. - MarketBeat
2,647 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Union Bancaire Privee UBP SA - MarketBeat
Amgen (AMGN) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Celltrion Settlement Puts Prolia And Xgeva Biosimilars On Ice – But Only Until June - News & Insights
Bensler LLC Sells 3,489 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Matrix Asset Advisors Inc. NY Has $24.25 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Price Target Cut to $295.00 by Analysts at Citigroup - MarketBeat
Analyst Expectations For Amgen's Future - Benzinga
BankPlus Wealth Management LLC Takes $475,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Citigroup Adjusts Price Target on Amgen to $295 From $310, Maintains Neutral Rating - Marketscreener.com
Lebenthal Global Advisors LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Foundations Investment Advisors LLC Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biotech Giant Amgen Launches Media Review 07/22/2024 - MediaPost Communications
Drive Wealth Management LLC Invests $236,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Expected to Announce Earnings on Tuesday - MarketBeat
This Is What Whales Are Betting On Amgen - Benzinga
Amgen Deal Blocks Celltrion's Bone-Drug Biosimilars Until June - Bloomberg Law
Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now? - MSN
Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer - GlobeNewswire Inc.
Baldwin Wealth Partners LLC MA Sells 1,282 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Granite Group Advisors LLC Has $2.29 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stake Cut by Marshall Financial Group LLC - MarketBeat
Exchange Traded Concepts LLC Purchases 1,464 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen opens new drug substance facility in North Carolina, US - Yahoo Finance
Avior Wealth Management LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Blue Square Asset Management LLC Acquires 7,277 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Jamison Private Wealth Management Inc. Buys 997 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Alan B Lancz & Associates Inc. - MarketBeat
DGS Capital Management LLC Has $392,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by SG Americas Securities LLC - MarketBeat
Amgen (NASDAQ:AMGN) Earns Outperform Rating from Royal Bank of Canada - MarketBeat
Fifth Third Bancorp Sells 17,755 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Dynamic Advisor Solutions LLC Acquires 4,094 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Gradient Investments LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Nepsis Inc. Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Secure Asset Management LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Pharma giant Amgen opens first Holly Springs facility, starts construction on second - AOL
Biotech giant Amgen celebrates opening of new campus in Holly Springs - ABC11 Raleigh-Durham
North Carolina Ribbon Cutting Marks Important Milestone in Expansion to Meet Growing Demand for Amgen Medicines - Amgen
Pharma giant kicks off billion-dollar expansion with second facility in North Carolina - The Business Journals
MFA Wealth Services Purchases Shares of 6,795 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Brighton Jones LLC Grows Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen opens one building, plans another, bringing biotech jobs to Holly Springs - WRAL News
Road to jobs worth $91K starts Friday - WRAL News
Cerro Pacific Wealth Advisors LLC Purchases 1,391 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Red Door Wealth Management LLC Has $7.60 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mutual Advisors LLC Sells 1,882 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's SWOT analysis: stock poised for growth amid obesity drug potential - Investing.com India
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):